Acceleration of murine amyloidosis by implantation of amyloid-containing grafts

References

• Fu X, Korenaga T, Fu L, Xing Y, Guo Z, Matsushita T, Hosokawa M, Naiki H, Baba S, Kawata Y, Ikeda S, et al. Induction of AApoAII amyloidosis by various heterogeneous amyloid fibrils. FEBS Lett 2004; 563: 179–184
   PubMedGoogle Scholar
• Niewold ThA., Gruys E, Kisilevsky R, Shirahama T S. Fibril amyloid enhancing factor (FAEF)-accelerated amyloidosis in the hamster is not dependent on senile esterase activity and mononuclear phagocytosis. Scand J Immunol 1991; 34: 101–107
   PubMed Web of Science ®Google Scholar
• Mambule C, Ando Y, Anan I, Holmgren G, Sandgren O, Stigbrandt T, Tashima K, Suhr O B. Enhancement of AA-amyloid formation in mice by transthyretin amyloid fragments and polyethylene glycol. Biochem Biophys Acta 2000; 1474: 331–336
   PubMed Web of Science ®Google Scholar
• Johan K, Westermark G, Engström U, Gustavsson Å, Hultman P, Westermark P. Acceleration of amyloid protein A amyloidosis by amyloid-like synthetic fibrils. Proc Natl Acad Sci USA 1998; 95: 2559–2563
   Google Scholar
• Ganowiak K, Hultman P, Engström U, Gustavsson Å, Westermark P. Fibrils from synthetic amyloid-related peptides enhance development of experimental AA-amyloidosis in mice. Biochem Biophys Res Comm 1994; 199: 306–312
   PubMed Web of Science ®Google Scholar
• Yokota T, Ishihara T, Kawano H, Takahashi M, Fujinaga Y, Uchino F. Amyloid enhancing factor (AEF) in the aging mouse. Virchows Arch A Pathol Anat Histopathol 1989; 414: 511–514
   PubMedGoogle Scholar
• Elliott-Bryant R, Cathcart E S. Amyloid enhancing factor and dietary transmission in accelerated amyloid A amyloidosis. Clin Immunol Immunopathol 1998; 88: 65–69
   PubMedGoogle Scholar
• Suhr O B, Herlenius G, Friman S, Ericzon B G. Liver transplantation for hereditary transthyretin amyloidosis. Liver Transpl 2000; 6: 263–276
   PubMed Web of Science ®Google Scholar
• Furtado A JL. Domino liver transplantation using FAP grafts. HUC experience-hopes and realities. Amyloid: J Protein Folding Disord 2003; 10(Suppl 1)84–87
   Google Scholar
• Suhr O B. Impact of liver transplantation on familial amyloidotic polyneuropathy (FAP) patients' symptoms and complications. Amyloid: J. Protein Folding Disord 2003; 10(Suppl 1)77–83
   PubMed Web of Science ®Google Scholar
• Ericzon B G, Larsson M, Herlenius G. Wilczek HE on behalf of reporting members of the FAPWTR: Report from the Familial Amyloidotic Polyneuropathy World Transplant Registry (FAPWTR) and the Domino Liver Transplant Registry (DLTR). Amyloid: J Protein Folding Disord 2003; 10(Suppl 1)67–76
   PubMedGoogle Scholar
• Ando Y. New therapeutic approaches for familial amyloidotic polyneuropathy (FAP). Amyloid: J Protein Folding Disord 2003; 10(Suppl 1)55–66
   PubMedGoogle Scholar
• Stangou A J, Heaton N D, Hawkins P N. Transmission of systemic transthyretin amyloidosis by means of domino liver transplantation [Case Reports. Letter]. N Engl J Med 2005; 352: 2356
   PubMed Web of Science ®Google Scholar
• Gruys E, Snel F W. Animal models for reactive amyloidosis. Bailliére's Clin Rheumatol 1994; 8: 599–611
   PubMed Web of Science ®Google Scholar
• Skinner M, Shirahama T, Benson M D, Cohen A S. Murine amyloid protein AA in casein-induced experimental amyloidosis. Lab Invest 1977; 36: 420–427
   PubMed Web of Science ®Google Scholar
• Imada N. Pathological study on amyloidosis, isolation and purification of amyloid fibril protein and biochemical and immunological analysis. Yamaguchi Med J 1981; 30: 149–162, (In Japanese)
   Google Scholar
• Higuchi K, Matsumura A, Honma A, Takeshita S, Hashimoto K, Hosokawa M, Yasuhira K, Takeda T. Systemic senile amyloid in senescence-accelerated mice. A unique fibril protein demonstrated in tissues from various organs by the unlabeled immunoperoxidase method. Lab Invest 1983; 48: 231–240
   PubMedGoogle Scholar
• Horwich A J, Weissman J S. Deadly conformations-Protein misfolding in Prion disease. Cell 1997; 89: 499–510
   PubMed Web of Science ®Google Scholar
• Lundmark K, Westermark G T, Nyström S, Murphy C L, Solomon A, Westermark P. Transmissibility of systemic amyloidosis by a prion-like mechanism. Proc Natl Acad Sci USA 2002; 99: 6979–6984
   PubMed Web of Science ®Google Scholar
• Higuchi K, Naiki N, Kitagawa K, Hosokawa M, Takeda T. Mouse senile amyloidosis. ASSAM amyloidosis in mice presents universally as a systemic age-associated amyloidosis. Virchows Archiv B Cell Pathol Incl Mol Pathol 1991; 60: 231–238
   PubMedGoogle Scholar
• Higuchi K, Kogishi K, Wang J, Chen X, Chiba T, Matsushita T, Hoshii Y, Kawano H, Ishihara T, Yokota T, Hosokawa M. Fibrilization in mouse senile amyloidosis is fibril conformation-dependent. Lab Invest 1998; 78: 1535–1542
   PubMed Web of Science ®Google Scholar
• Schenk D, Barbour R, Dunn W, Gordon G, Grajeda H, Guido T, Hu K, Huang J, Johnson-Wood K, Khan K, Kholodenko D, et al. Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature 1999; 400: 173–177
   PubMed Web of Science ®Google Scholar